Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Thursday, May 14, 2026

Lucintel Forecasts the Global Disposable Hypodermic Syringe Market to Grow with a CAGR of 5.2% from 2025 to 2031

According to a market report by Lucintel, the future of the global disposable hypodermic syringe market looks promising with opportunities in the hospital & clinic and diagnostic laboratory markets. The global disposable hypodermic syringe market is expected to grow with a CAGR of 5.2% from 2025 to 2031. The major drivers for this market are the increasing demand for safe injection practices, the rising use in vaccination & immunization, and the growing awareness of needlestick injury prevention.

A more than 150-page report to understand trends, opportunity and forecast in global disposable hypodermic syringe market to 2031 by type (conventional syringes and safety syringes), application (hospitals & clinics, diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that, within the type category, safety syringe is expected to witness higher growth over the forecast period.

Within the application category, hospital & clinic is expected to witness higher growth.

Download sample by clicking on disposable hypodermic syringe market.

In terms of region, APAC is expected to witness the highest growth over the forecast period.

BD, Terumo, Cardinal Health, Nipro Corp, Merit Medical, B. Braun, ICU Medical, Hindustan Syringes & Medical Devices, Feel Tech Bio, WEGO are the major suppliers in the disposable hypodermic syringe market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email:
roy.almaguer@lucintel.com
Tel. +1-972-636-5056

Explore Our Latest Publications

Cetirizine Hydrochloride Market

Clinical Data Management System Market

Conductive Point Level Switch Market

Connected Wearable Patch Market

Controller Area Network Market

No comments:

Post a Comment